Spine companies are operating in an intensely competitive market that for years rewarded share and scale. That dynamic is shifting.
Today, enabling technologies are no longer optional add-ons but essential components of strategic growth. The companies rising in spine are building strong technology portfolios.
Mid-tier players such as Orthofix and ATEC are proving that investing in enabling technologies can pay off, while newer entrants like Augmedics and OnPoint Surgical continue to attract investment in augmented reality–based navigation.
At the same time, larger companies are reevaluating what truly drives differentiation. Notably, Stryker’s divestment of its spine implant business to VB Spine didn’t include the Mako Spine robot. The move underscored the importance that Stryker has staked in enabling technology in its efforts to compete with spine’s biggest players.
“Mako has the necessary capabilities, a strong install base and a sophisticated team that’s developing the platform,” said Keith Evans, Vice President and General Manager of Stryker’s enabling technology business. “It became an obvious choice for us to go all in on Mako. We’ve aligned those efforts with the work being done by the hip, knee and shoulder teams on the same platform.”
In this environment, incremental improvements to implants are no longer enough to secure lasting market share. While implant innovation remains essential, differentiation increasingly depends on the technologies that surround the implant — tools that enable more precise placement, optimize surgical efficiency and generate actionable data.
Enabling technologies are emerging as the connective tissue between preoperative intent and postoperative results. For spine companies, they offer not only clinical value, but also a strategic pathway to sustained relevance in a crowded and fast-evolving field.
By Kendal Kloiber | BONEZONE
Image Credit: Stryker